Loading...
Loading...
Application UK00903919081 · Registered

| Application Number | UK00903919081 |
| Status | Registered |
| Owner | Dendreon Pharmaceuticals LLC |
| Filed | 2004-07-12 |
| Registered | 2005-11-16 |
| Renewal Due | 2034-07-12 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. Dendreon is currently a registered UK trademark, with renewal due on 2034-07-12. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Kits for cell separation, cells, reagents, antibodies, and antigens for scientific and laboratory research and use.
Pharmaceuticals for use in the treatment of cancer, infectious and autoimmune diseases; pharmaceuticals, antibodies, and antigens for use in the prevention and treatment of cancer, autoimmune and infectious diseases and disorders, and allergies; pharmaceuticals for use in the prevention and treatment of genetically induced conditions, diseases and disorders; kits for cell separation for medical and clinical use; cells for medical and clinical use; kits for cell separation, cells, reagents, antibodies, and antigens for pharmaceutical, veterinary and medical research and use.
Research and development of pharmaceutical products for others; research and development services in the fields of medicine, pharmaceuticals, pharmacology, immunotherapy, and veterinary science.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'Dendreon' is a registered trademark on the UK IPO register, owned by Dendreon Pharmaceuticals LLC. The application (UK00903919081) was filed on 12 July 2004 and registered on 16 November 2005. The registration is set to expire on 12 July 2034.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services).
The trademark is represented by Swindell & Pearson Ltd.
UK trademark UK00903919081 for the mark 'Dendreon' in Class 1, 5, 42 is recorded on the UK IPO register as owned by Dendreon Pharmaceuticals LLC. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00903919081 for the mark 'Dendreon' as registered.
UK trademark UK00903919081 for the mark 'Dendreon' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 1: Kits for cell separation, cells, reagents, antibodies, and antigens for scientific and laboratory research and use. | Class 5: Pharmaceuticals for use in the treatment of cancer, infectious and autoimmune diseases; pharmaceuticals, antibodies, and antigens for use in the prevention and treatment of cancer,…
UK trademark UK00903919081 for the mark 'Dendreon' was filed at the UK IPO on 12 July 2004 and registered on 16 November 2005.
UK trademark UK00903919081 for the mark 'Dendreon' is currently recorded as valid until 12 July 2034, at which point it will need to be renewed with the UK IPO to remain in force.
Swindell & Pearson Ltd is listed as the attorney / representative of record for UK trademark UK00903919081 for the mark 'Dendreon' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "Dendreon" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| DENDREONSame applicant | 90260931 | 700 | 2020-10-17 |
| DENDREON TARGETING CANCER, TRANSFORMING LIVESSame applicant | 90260940 | 606 | 2020-10-17 |
| DENDREONSame applicant | 90242350 | 700 | 2020-10-08 |
| DENDREONSame applicant | 90242675 | 700 | 2020-10-08 |
| DENDREON TARGETING CANCER, TRANSFORMING LIVESSame applicant | 90243305 | 700 | 2020-10-08 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.